Streetbeat News

Stock Prices

BLBD

Wall Street analysts are optimistic about Blue Bird (BLBD), which may influence investor decisions and impact the stock's price.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

ENGN

enGene Holdings Inc. (ENGN) has experienced a significant decline of 16.9% over the past four weeks, placing it in oversold territory. However, with Wall Street analysts raising earnings estimates, a potential trend reversal is anticipated.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

ASTS

Wall Street analysts are optimistic about AST SpaceMobile (ASTS), which may influence investor decisions. Analyst ratings can impact stock prices, but their significance is debated.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

MQ

A securities class action lawsuit has been filed against Marqeta, Inc. in the Northern District of California. The lawsuit is for investors who acquired Marqeta securities between August 7, 2024, and November 4, 2024. The lead plaintiff deadline is February 7, 2025.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

ROP

Roper Technologies (ROP) is experiencing solid momentum across its segments, benefiting from accretive acquisitions and shareholder-friendly policies. These factors make it a strong candidate for portfolio addition.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

BSX

Boston Scientific (BSX) is under consideration as a potential buy, with Wall Street analysts showing optimism. Analyst recommendations can significantly influence stock prices.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

TMC

The Schall Law Firm is urging investors to participate in a class action lawsuit against TMC the metals company Inc. for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934. Investors who bought TMC securities between May 12, 2023, and March 25, 2024, should contact the firm by January 7, 2025.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

BIOA

Levi & Korsinsky has initiated an investigation into BioAge Labs, Inc. (BIOA) for potential securities fraud following the discontinuation of its STRIDES Phase 2 trial due to safety concerns. This could impact investor confidence and the company's stock price in the short term.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

PACS

A securities fraud class action lawsuit is pending against PACS Group, Inc. Investors who suffered losses are encouraged to contact Levi & Korsinsky before January 13, 2025, to discuss potential recovery under federal securities laws.

Portfolio Pulse from

December 13, 2024 | 3:45 pm

MU

Micron (MU) is set to release its Q1 earnings, with analysts focusing on key performance metrics to assess the company's performance for the quarter ending November 2024.

Portfolio Pulse from

December 13, 2024 | 3:30 pm